Updates matching "Idaho"

Idaho’s 2020 legislative session has come to an end. While the American Cancer Society Cancer Action Network (ACS CAN) did not have a major legislative victory during the session, there is certainly a lot of positive news that we can report. The session ended with growing concern about COVID-19 and

Boise, Idaho— Idaho student advocates, with the support of the American Cancer Society Cancer Action Network (ACS CAN), have organized a virtual day at the capitol with Senate legislative leadership to discuss the youth epidemic, tobacco control policy, and health issues facing them and their peers today. The event will

This year roughly 10,240 Idahoans will be diagnosed with cancer. Thanks in part to advances in cancer research and treatment, we are saving more lives than ever. But cancer remains a critical public health problem and getting new and affordable therapies from the research lab to the patient will require

An upcoming cancer forum on September 24 th in Boise will feature a keynote address by Dr. Bonnie Halpern-Felsher, one of the country’s top tobacco researchers. Halpern-Felsher will speak about Big Tobacco’s strategy to hook youth into a lifetime of addiction through aggressive marketing and enticing candy, fruit and menthol

Idaho is falling short when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer. According to the latest edition of How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality, Idaho measured up to

BOISE, Idaho – Idaho is falling short when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer. According to the latest edition of How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality,

This week ACS CAN participated in a chemotherapy informational hearing at the State Capitol on the unequal cost cancer patients incur for oral (pill and liquid) versus intravenous (IV) chemotherapies on Idaho’s state-based health care plans. As targeted oral chemotherapy advances, it is apparent that the most effective or, in